Incyte Diagnostics announces new leadership

Washington Hospital Services Industry Partner Incyte Diagnostics has announced two new leadership changes they would like to announce to WSHA members. Tom Rehwald has assumed the responsibilities of CEO, and Tom Legel has become the new CFO. The full details of these exciting developments can be found here. To learn more about Incyte Diagnostics or any of our other Industry Partners, please visit our website or contact Paul Unsworth at (206) 577-1806. (Paul Unsworth)